WebPharmaceuticals. Granules India is a vertically integrated, high-growth pharmaceutical company with 38 years of proven performance and increasing presence across the … WebThe Granules India PE ratio based on its reported earnings over the past 12 months is 11.45.The shares last closed at IN₹285.45.. The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors.
Did you know?
WebJul 21, 2024 · Hyderabad, July 21, 2024: Granules India Limited announced that Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the Company located in Chantilly, Virginia, USA had undergone a Pre- Approval Inspection (PAI) audit by the U.S. Food and Drug Administration (FDA) from 21 st June 2024 to 25 th June 2024. The audit … WebJan 28, 2024 · View 12 reports from 6 analysts offering long term price targets for Granules India Ltd.. Granules India Ltd. has an average target of 375.83. The consensus estimate represents an upside of 25.53% from the last price of 299.40. Reco - This broker has downgraded this stock from it's previous report.
WebTrospium Chloride Extended-release Capsules. Details. Valganciclovir Hydrochloride for Oral Solution, USP. Details. Vigabatrin for Oral Solution, USP. Details. Bupropion … WebGet the latest Granules India Ltd (GRANULES) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
WebJul 27, 2024 · Granules Pharmaceutical Inc. (GPI), Chantilly, VA, a wholly owned subsidiary of Granules India Limited, would like to clarify that there has been no … WebJan 29, 2024 · See 12 recent research reports for GRANULES, BSE:532482 Granules India Ltd. from 6 source(s) with an average share price target of 376. Markets Today Top Gainers ADANIGREEN 4.33%. ATGL 3.63%. Top Losers CHOLAFIN -0.89%. PGHH -0.59%. Discover: Search filings ...
WebCheck Granules India share price, financial data and complete stock analysis.Get Granules India stock rating based on quarterly result, profit and loss account, balance sheet, shareholding pattern and annual report. ... NSE: GRANULES BSE: 532482 SECTOR: Pharmaceuticals & Drugs 102k 1k 207. 297.50-4.15 (-1.38%) NSE: Today, …
WebGranules Pharmaceuticals, Inc. 6,556 followers on LinkedIn. Granules Pharmaceuticals, Inc. is a pharmaceuticals company based out of 3701 CONCORDE PKY, Chantilly ... can nature get it rightWebSep 3, 2024 · Sep 3, 2024. Granules Pharmaceuticals Inc., the North American subsidiary of an Indian drug manufacturer, is growing in Northern Virginia again. The company has signed a lease for 79,000 square ... can natural supplements affect birth controlWebMar 21, 2024 · Bombay Stock Exchange; Granules India Limited. News. Summary 532482 INE101D01020. GRANULES INDIA LIMITED (532482) Add to my list. Report ... Granules USA, Inc. & Granules Pharmaceuticals, Inc. Granules Consumer Health (GCH) is a leading private-label OTC provider, and its packaging facility will enable it to service … fix my airWebJul 3, 2024 · Granules India announced that its subsidiary, Granules Pharmaceuticals Inc. is voluntarily recalling twelve (12) lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500 count bottles within expiry to the consumer level due to the detection of N- Nitrosodimethylamine (NDMA) levels above the Acceptable Daily Intake … fix my ampWebApr 11, 2024 · 532482 Stock Overview. Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. About the company fix my air car conditionerWeb14 hours ago · Apr 14, 2024 (The Expresswire) -- The Global Ibuprofen Market research report for 2024-2030 provides a detailed analysis of the current market scenario, including qualitative and quantitative ... can nature reduce stressWebStock Quotes: Get all stocks market quotes, company stocks price quotes in India. ... Shares of Gland Pharma, Lupin and Granules India declined 2-2.5% in Monday's trade. Aurobindo Pharma, Pfizer, Zydus Lifesciences, GlaxoSmithKline Pharmaceuticals, and Sanofi India were also trading with cuts. Stock market update: Nifty Pharma index falls … fix my air conditioner car